Medications for Neuroblastoma

15 results

  • Adreview (iobenguane i-123)

    (Iobenguane I-123)
    Medi-Physics Inc.
    Usage: AdreView is indicated for detecting primary or metastatic pheochromocytoma and neuroblastoma, and for assessing sympathetic innervation in patients with congestive heart failure (NYHA class II or III, LVEF ≤ 35%). It aids in identifying lower mortality risks but is not for therapy selection or monitoring.

  • Cyclophosphamide (cyclophosphamide for injection)

    (Cyclophosphamide for Injection)
    Slate Run Pharmaceuticals, LLC
    Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.

  • Cyclophosphamide (cyclophosphamide injection, solution)

    (cyclophosphamide injection, solution)
    Baxter Healthcare Corporation
    Usage: Cyclophosphamide Injection is indicated for treating malignant lymphomas, multiple myeloma, various leukemias, advanced mycosis fungoides, disseminated neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is often used alone or in combination with other antineoplastic agents.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Dr. Reddy's Laboratories Inc.
    Usage: Cyclophosphamide is indicated for treating malignant diseases in adults and pediatric patients, including various lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is often used in combination with other antineoplastic agents.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Civica, Inc.
    Usage: Cyclophosphamide for Injection is indicated for treating various malignant diseases in adults and children, including malignant lymphomas, multiple myeloma, leukemias, and neuroblastoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to or cannot tolerate corticosteroids.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    NorthStar RxLLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases, including certain lymphomas, multiple myeloma, leukemias, advanced mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome unresponsive to corticosteroids.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, and certain solid tumors. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who have not responded to corticosteroid therapy. Safety in adults for nephrotic syndrome is unestablished.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for the treatment of various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and several cancers such as ovarian and breast carcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who do not respond to corticosteroids.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    NextSource Pharma
    Usage: Cyclophosphamide Capsules are indicated for treating various malignant diseases, including malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.